Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/2522
Title: | Experience of using uperio in patients with chronic heart failure |
Authors: | Musaeva L.J., Akbarova D.S., Pulatova D.B., Pulatova N.I., Abdusamatova D.Z., Islomova M.Sh. |
Keywords: | Experience of using uperio, patients with chronic heart failure |
Issue Date: | 2022 |
Publisher: | Toshkent |
Abstract: | We examined 30 patients with coronary heart disease, angina pectoris FC III, the course of which was complicated development of CHF II-III Art. FC III (NYHA). In 19 patients in history large-focal myocardial infarction was detected, in 5 patients - left ventricular aneurysm, in 25 - arterial hypertension, in 11 - a permanent form of atrial fibrillation. The disease proceeded against the background of diabetes mellitus in 8 patients. Average age of patients was 60,4±1,7 years. All patients received for 2 months the drug Uperio 50 mg (valsartan 25,7 mg + sacubitril 24,3 mg) against the background of conventional CHF therapy, including ACE inhibitors, beta-blockers, diuretics and cardiac glycosides. Initially and after 2 months treatmentwith Uperio, all patients underwent a general clinical examination, ECG registration, Echocardiography, 6-minute walk test, assessment of quality of life and clinical condition |
URI: | http://repository.tma.uz/xmlui/handle/1/2522 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
100 yil tezislar to'plami (2) 113стр.pdf | Experience of using uperio in patients with chronic heart failure | 8.57 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.